Witnessing the stock’s movement on the chart, on Wednesday, Cassava Sciences Inc (NASDAQ: SAVA) set off with pace as it heaved 4.40% to $1.66, before settling in for the price of $1.59 at the close. Taking a more long-term approach, SAVA posted a 52-week range of $1.15-$42.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -40.61%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 62.33%. This publicly-traded company’s shares outstanding now amounts to $48.20 million, simultaneously with a float of $41.98 million. The organization now has a market capitalization sitting at $76.81 million. At the time of writing, stock’s 50-day Moving Average stood at $2.1246, while the 200-day Moving Average is $13.6306.
Cassava Sciences Inc (SAVA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Cassava Sciences Inc’s current insider ownership accounts for 13.11%, in contrast to 36.15% institutional ownership. According to the most recent insider trade that took place on Nov 29 ’24, this organization’s Chief Medical Officer sold 4,000 shares at the rate of 3.87, making the entire transaction reach 15,480 in total value, affecting insider ownership by 0. Preceding that transaction, on Nov 29 ’24, Company’s Chief Financial Officer sold 59,800 for 3.86, making the whole transaction’s value amount to 230,828. This particular insider is now the holder of 11,500 in total.
Cassava Sciences Inc (SAVA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Cassava Sciences Inc’s EPS increase for this current 12-month fiscal period is 62.33%.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Let’s observe the current performance indicators for Cassava Sciences Inc (SAVA). It’s Quick Ratio in the last reported quarter now stands at 11.62. The Stock has managed to achieve an average true range (ATR) of 0.17.
In the same vein, SAVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.45.
Technical Analysis of Cassava Sciences Inc (SAVA)
Going through the that latest performance of [Cassava Sciences Inc, SAVA]. Its last 5-days volume of 1.0 million was inferior to the volume of 1.9 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 88.21% While, its Average True Range was 0.1519.
Raw Stochastic average of Cassava Sciences Inc (SAVA) in the period of the previous 100 days is set at 16.04%, which indicates a major fall in contrast to 87.93% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 84.28% that was lower than 100.68% volatility it exhibited in the past 100-days period.
